Tag: Eli Lilly and Co
-
Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.
Lilly’s Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk’s Wegovy beyond the U.S. market.
-
Looking for strong returns outside of AI? Buy these ‘non-tech compounders,’ says Trivector Research
Volatility in July reminded investors of the risks tied to increasingly crowded trades powered by the AI boom and a massive run in semiconductor shares.
-
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.
-
We’re increasing our Eli Lilly price target after another beat-and-raise quarter
The strength of its GLP-1 business suggests the stock still has more room to run.
-
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
-
CVS blows past estimates, hikes guidance as insurance unit continues to improve
CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patients on the CVS Health app.
-
CNBC Daily Open: Markets rally on hopes of Iran-U.S. Strait of Hormuz deal
U.S. Treasury Secretary Scott Bessent told CNBC that Iran and the U.S. could reach a deal to open the Strait of Hormuz by Wednesday.
-
Novo Nordisk’s raised forecast fails to change the debate over its obesity business
Wall Street isn’t convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.
-
Novo Nordisk shares slide after guidance disappoints investors
Novo Nordisk raised its financial outlook as it tries to catch up with rival Eli Lilly in the booming GLP-1 market.
-
Here are some of JPMorgan’s favorite stocks as August trading kicks off
As August starts, JPMorgan analysts chose their favorite stocks to outperform this month.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
